news
ADHD stimulants show early promise for perimenopausal brain fog
Between 44% and 60% of women report sharp cognitive slumps during perimenopause. New data presented by researcher Jennifer Tat at The Menopause Society meeting suggests ADHD medications might restore that lost executive function.
Between 44% and 60% of women report sharp cognitive slumps during perimenopause. New data presented by researcher Jennifer Tat at The Menopause Society meeting suggests ADHD medications might restore that lost executive function.
The architecture take
I spent two years assuming midlife brain fog was entirely an estrogen story, but the neurochemistry is much messier. When estrogen dives, dopamine and norepinephrine downshift right alongside it in the prefrontal cortex, which leaves working memory stranded. That is why so many women at 47 feel like they suddenly developed attention deficit disorder out of nowhere. Clinicians usually hand out hormone therapy or an SSRI, but neither reliably turns the lights back on when executive function tanks. Stimulants directly nudge dopamine transmission back to baseline. I suspect psychiatrists will start writing off-label prescriptions for low-dose Vyvanse or methylphenidate well before clinical guidelines officially catch up. The regulatory boards will probably drag their feet over abuse potential, but patients do not care about bureaucratic caution when they cannot remember their own passwords. Watch this become standard private practice within eighteen months.